Chad M. Robins, CEO and Chairman at Adaptive Biotechnologies Corp (ADPT), sold 120,595 shares at $14.41 ($1.8M) on 2026-04-06, disclosed to the SEC on 2026-04-08.
Scheduled sale ($1.8M) by CEO and Chairman under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.41 | 83,332 | $1.2M | 68.0% |
| 2 | $15.19 | 37,263 | $566K | 32.0% |
| Total | $14.65 avg | 120,595 | $1.8M | 100% |
| Filing → |
| ADPT | SELL | 2026-03-03 | $8.3M | — | Filing → |
| ADPT | SELL | 2026-02-04 | $2.3M | — | Filing → |
| ADPT | SELL | 2026-01-07 | $1.9M | — | Filing → |